Netflix Inc (NFLX) 419.64 $NFLX S&P 500 Pops 1%, Dow

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2015 at 2:08 PM

Netflix Inc (NFLX) 419.64 $NFLX

S&P 500 Pops 1%, Dow Jumps Triple Digits Ahead of Fed Meeting
at The Street - 18 mins ago
Stocks rocket more than 1% higher, erasing some of the losses suffered last week.
BID: 40.99 (+0.46), TSLA: 193.99 (+5.31), GE: 25.40 (+0.36), VRX: 201.71 (+4.28), SLXP: 172.79 (+3.39), DIS: 107.41 (+0.97), XLV: 73.24 (+1.43), NFLX: 419.64 (-18.76), MSG: 76.99 (-1.20), PG: 83.32 (+1.49)

HBO's Durst Series Shows Documentaries May Be the Next Big Thing
at The Street - 26 mins ago
As the cost to produce television serials keeps rising because of increased competition, documentaries are assuming a higher role in HBO's quest for original content.
NFLX: 419.64 (-18.76), TWX: 85.31 (+1.22), STRZA: 34.13 (+0.39), CBS: 61.90 (+0.97)

Stocks Near Session Highs; Tesla Up On Musk Tweet
at Investor's Business Daily - 1 hr 58 mins ago
Stocks were holding near session highs going into the noon hour Monday, although volume was tracking lower in the stock market today. Crude oil dropped nearly 4%, bring West Texas Intermediate below 44, its lowest level since late January. Tesla...
AGN: 240.87 (+3.53), NFLX: 419.64 (-18.76), ENDP: 89.23 (+1.90), TSLA: 193.99 (+5.31), ACT: 303.65 (+4.70), VRX: 201.71 (+4.28), SLXP: 172.79 (+3.39), EW: 148.01 (+12.66)

NanoTech Entertainment: On The Verge Of Something Big?
Matt's Stocks - Seeking Alpha - 2 hrs 14 mins ago
Recent events have peeked my interest in NanoTech Entertainment ( OTCPK:NTEK ). Sometimes, the best investing knowledge is that gained by your own interactions in the market. I needed to purchase three new HD televisions due to renovations and...
NFLX: 419.64 (-18.76), AMZN: 372.53 (+1.95), LGF: 33.88 (+0.62), SNE: 25.82 (-0.74), GOOGL: 563.10 (+10.10), GOOG: 555.90 (+8.58)

Stocks Follow Europe, China Higher; Oil Tumbles to 6-Year Low
at The Street - Mon Mar 16, 10:02AM CDT
Stocks surge on Monday, following European and Asian markets higher.
BID: 40.99 (+0.46), ENDP: 89.23 (+1.90), TSLA: 193.99 (+5.31), GE: 25.40 (+0.36), VRX: 201.71 (+4.28), SLXP: 172.79 (+3.39), NFLX: 419.64 (-18.76), MSG: 76.99 (-1.20), PG: 83.32 (+1.49), MSFT: 41.39 (+0.01)

Netflix Stock Downgraded, Seen Lagging HBO Content
at Investor's Business Daily - Mon Mar 16, 9:03AM CDT
Netflix (NFLX) faces growing U.S. competition as its costs rise to expand overseas, says Evercore ISI, and its content lags that of rival HBO. The investment bank on Monday downgraded Netflix stock to sell. Netflix stock was down 3.5% in early...
NFLX: 419.64 (-18.76), YHOO: 43.60 (+0.73), AMZN: 372.53 (+1.95), FB: 77.67 (-0.38), DIS: 107.41 (+0.97), AAPL: 124.22 (+0.63), TWX: 85.31 (+1.22)

Netflix (NFLX) Stock Falling Today After Ratings Cut
at The Street - Mon Mar 16, 8:03AM CDT
Netflix (NFLX) stock is lower this morning after the company had its rating lowered to 'sell' from 'hold' at Evercore.
NFLX: 419.64 (-18.76)

Evercore calls a top on Netflix
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 5:57AM CDT

NFLX: 419.64 (-18.76)

Earnings Quality At Netflix Is Subpar
Valuentum - at Seeking Alpha - Sun Mar 15, 3:50PM CDT

NFLX: 419.64 (-18.76)

The Business Risks of Tying Up $224 Billion in Unused Vacation Days
Casey Kelly-Barton, The Motley Fool - Motley Fool - Sun Mar 15, 2:27PM CDT
America's private sector has a liability of $224 billion in unused vacation days, per the latest report from the U.S. Travel Association's Project: Time Off . For all the media talk about work-life balance, the problem of unused time off is...
NFLX: 419.64 (-18.76), TZOO: 9.67 (+0.04), HUBS: 38.12 (-1.28)

Adding A Few High Flyers To A Growth Portfolio
Abba's Aces - at Seeking Alpha - Sun Mar 15, 1:01PM CDT

NFLX: 419.64 (-18.76), BIIB: 420.13 (+6.78), FB: 77.67 (-0.38), RAD: 7.43 (-0.02)

Why Is the Netflix Streaming List So Limited?
Bradley Seth McNew, The Motley Fool - Motley Fool - Sun Mar 15, 8:45AM CDT
Logo: Netflix Netflix has been a leader in helping consumers cut the cable cord. Its video streaming content gives users an option other than paying an expensive cable bill for many channels they might not watch, at a monthly price generally...
NFLX: 419.64 (-18.76)

The Average American Watches This Much TV Every Day: How do You Compare?
Demitrios Kalogeropoulos, The Motley Fool - Motley Fool - Sun Mar 15, 8:33AM CDT
If you watch less than five hours of television each day, then consider yourself below average. The typical American spent 4 hours and 51 minutes in front of a TV screen per day over the last few months, according to a report from ratings company...
NFLX: 419.64 (-18.76), DISCA: 32.42 (+0.39), DIS: 107.41 (+0.97)

Need For Speed: Making The Case For Net Neutrality
The Intercollegiate Finance Journal - at Seeking Alpha - Sun Mar 15, 12:50AM CDT
Imagine you're driving on the highway when you come to a fork in the road. On the right is a tollbooth charging the standard fee; on the left is another tollbooth charging double the price. Most people take the right lane, of course, but if you're...
NFLX: 419.64 (-18.76), T: 33.01 (+0.25), VZ: 49.22 (+0.38), CMCSA: 59.62 (+0.57), TWX: 85.31 (+1.22)

Why HBO Can Charge Almost Twice As Much As Netflix
Sam Mattera, The Motley Fool - Motley Fool - Sat Mar 14, 10:14AM CDT
Coming in April, HBO will launch HBO Now, its very own Netflix competitor. For $14.99 per month, HBO Now subscribers will be able to access all of HBO's content over the Internet -- no expensive cable package required. Cord-cutters have long...
NFLX: 419.64 (-18.76), AMZN: 372.53 (+1.95), TWX: 85.31 (+1.22)

3 (Legal) Ways to Get Pay TV Without Paying for It
Daniel B. Kline, The Motley Fool - Motley Fool - Sat Mar 14, 9:13AM CDT
With the average American household paying around $80 a month for cable television, the temptation to cut the cord with Comcast , Time Warner Cable , Cablevision , or any of the other providers is great. The problem is that while cable is...
NFLX: 419.64 (-18.76), AMZN: 372.53 (+1.95), FOX: 33.48 (+0.50), WWE: 16.52 (-0.16), TWC: 157.68 (+2.71), CMCSA: 59.62 (+0.57), DISH: 73.46 (-0.36), CVC: 18.24 (+0.38), CBS: 61.90 (+0.97)

Apple TV vs. Amazon Fire TV: Which Should You Choose?
Daniel B. Kline, The Motley Fool - Motley Fool - Sat Mar 14, 9:00AM CDT
Apple TV offers a variety of popular streaming services. Source: Apple While most of the hype from Apple's "Spring Forward" event centered on its new Apple Watch and updated MacBook, the company also cut the price of its Apple TV from $99 to ...
NFLX: 419.64 (-18.76), AMZN: 372.53 (+1.95), AAPL: 124.22 (+0.63), DISH: 73.46 (-0.36)

1 Catch HBO Fans Should Know About It's New Service
Adam Levy, The Motley Fool - Motley Fool - Sat Mar 14, 7:02AM CDT
Cord-cutters looking to get their Game of Thrones fix through HBO's new over-the-top service, HBO Now, are out of luck if they don't have an Apple device with which to sign up. The Time Warner subsidiary inked a deal with the tech giant for a...
NFLX: 419.64 (-18.76), CMCSA: 59.62 (+0.57), AAPL: 124.22 (+0.63), TWX: 85.31 (+1.22)

A Jerry big deal: 'Seinfeld' near streaming agreement
Seeking Alpha - at Seeking Alpha - Sat Mar 14, 7:00AM CDT

NFLX: 419.64 (-18.76), AMZN: 372.53 (+1.95), YHOO: 43.60 (+0.73), FOXA: 34.41 (+0.39), DIS: 107.41 (+0.97), SNE: 25.82 (-0.74), CMCSA: 59.62 (+0.57), TWX: 85.31 (+1.22)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Mar 13, 7:32PM CDT
Cramer will be listening and learning next week as Foot Locker, FedEx, Oracle and Darden report.
MNST: 137.26 (+1.78), EA: 56.23 (+0.93), NKE: 96.43 (+0.62), WSM: 82.92 (+0.77), XL: 36.74 (+0.55), LUV: 45.30 (+0.79), ACAD: 34.35 (-0.10), DLTR: 83.51 (+1.60), COG: 28.07 (-0.05), FL: 61.23 (-0.08), REGN: 448.00 (+18.62), FDX: 177.12 (+3.80), BLUE: 123.37 (+3.44), MLM: 142.15 (+0.34), VMC: 85.01 (+0.40), ICE: 232.61 (+3.52), ORCL: 43.17 (+0.79), DRI: 64.37 (+1.27), WWAV: 41.82 (+0.06), NFLX: 419.64 (-18.76), TTWO: 25.77 (+0.34), UA: 76.96 (+0.91), FSLR: 59.44 (-1.16), AZO: 662.39 (+7.73), PLAY: 30.98 (+0.02), GIS: 52.21 (+0.06), CRM: 65.92 (+1.32)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...